CITU State vice-president D. Govinda Rao on Wednesday urged the State government to direct Aurobindo Pharma Limited to implement charter of demands since the previous wage agreement was lapsed in March, 2018. The CITU organised ‘Maha Dharna’ at the Srikakulam Collector’s office as part of the State-wide agitations over the pending issues of Aurobindo Pharma’s … Read more
Aurobindo Pharma Limited urged Srikakulam district administration to ensure peaceful work atmosphere in and around the factory located at Pydibhimavaram while alleging that the trade unions were trying to create industrial unrest in spite of payment of salaries and wages promptly with the directive of the Labour Department. In a press release on Monday, the … Read more
Aurobindo Pharma on Friday said the US Food and Drug Administration (USFDA) inspection of its Unit IV, a general injectable formulation manufacturing facility here, is “still open and under review.” This follows the regulator rescinding a 90-day VAl (Voluntary Action Initiated) letter it had issued to the company on February 18. In a regulatory filing, … Read more
A senior official in the US Food and Drug Administration (USFDA) office in India has emphasised the importance of effective and timely communication from pharma companies in their engagement with the health regulator. Companies that had been issued Form 483, post an USFDA inspection, have to respond within 15 days. They can seek more time … Read more
Union Minister of Commerce and Industry Piyush Goyal has proposed a meeting of the pharma industry to discuss issues that it faced and find solutions to them. “Sometime in the second week of March, I will get the pharma industry together to spend a day with me. Let’s dissect various issues plaguing the industry,” … Read more